glp-1 receptor agonist type 1 diabetes randomized trial agonists and next-generation metabolic hormone therapies in chronic kidney disease GLP-1 receptor agonists and diabetic

Benastatins C and D, new inhibitors of glutathione S-transferase, produced by Streptomyces sp

The discovery trajectory of orforglipron, from its origins at Chugai Pharmaceutical in Japan to global Phase 3 development by Eli Lilly, illustrates how persistent scientific innovation can overcome what was once considered a pharmacological impossibility

Many people may overlook the relevance of diet to increase their glutathione levels, but incorporating specific foods can make a notable difference

Effect of pulsed electric fields on mannoproteins release from Saccharomyces cerevisiae during the aging on lees of Caladoc red wine